11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.
about
Methods to Increase the Metabolic Stability of (18)F-RadiotracersNeurofunctional imaging of β-cell dynamicsGlucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic SuccessesImaging pancreatic islet cells by positron emission tomographyQuantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging.Characterization of 5-(2- 18F-fluoroethoxy)-L-tryptophan for PET imaging of the pancreas.Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo.Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.Imaging pancreas in healthy and diabetic rodent model using [18F]fallypride positron emission tomography/computed tomography.Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant modelGlucagon-like peptide-1 (GLP-1) analogs: recent advances, new possibilities, and therapeutic implications.Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligandsDecreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PETMultimodality imaging of β-cells in mouse models of type 1 and 2 diabetesObstacles on the way to the clinical visualisation of beta cells: looking for the Aeneas of molecular imaging to navigate between Scylla and Charybdis.Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibodyCross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas.Islet β cell mass in diabetes and how it relates to function, birth, and death.Imaging of beta-cell mass and functionIn vivo beta-cell imaging with VMAT 2 ligands--current state-of-the-art and future perspective.Life and death of β cells in Type 1 diabetes: A comprehensive review.Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes.In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET.Deletion of β-Arrestin2 in mice limited pancreatic beta-cell expansion under metabolic stress through activation of JNK pathway.Bcl-2-functionalized ultrasmall superparamagnetic iron oxide nanoparticles coated with amphiphilic polymer enhance the labeling efficiency of islets for detection by magnetic resonance imaging.Imaging the islet graft by positron emission tomography.Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetes.Beta-cell imaging: call for evidence-based and scientific approach.Imaging beta-cell mass and function in situ and in vivo.Biomarkers in type 1 diabetes: application to the clinical trial setting.Combination immunotherapies for type 1 diabetes mellitus.Pancreatic β-cell imaging in humans: fiction or option?Pancreas-Specific Delivery of β-Cell Proliferating Small Molecules.Failed PET Application Attempts in the Past, Can We Avoid Them in the Future?In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use.GPR44 is a pancreatic protein restricted to the human beta cell.Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)γa as a highly specific biomarker of pancreatic beta cells.Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis.The long road to pancreatic islet transplantation.
P2860
Q26781407-872523BD-CEC6-4307-B7C0-DA40127930B9Q26829645-CA30985B-132E-4926-97AD-DC6D66207803Q28067465-C309B873-4EC3-46C5-B270-B16D09F509D1Q28075496-D21AAAED-908A-4AC6-A3DD-46E24EB81347Q30364628-0F5E23CE-4D6D-4566-8D43-8026F1979793Q30828947-A0F2F0C9-C155-4979-BCE3-B31BB33CB369Q33480823-15FE22A2-EBEC-45A5-A3DC-1034B5815226Q34014474-E7F4AD0D-1FD6-4B50-B551-7B2A75B32240Q34283950-9BEFE314-A78B-4460-9C8D-DC1E49026C90Q35028182-40149144-5C2F-4C93-9546-426CDCB6969EQ35087846-98C1DB17-559F-442A-BA47-8A504FD47973Q35651214-BB934215-7888-4217-8B32-95F9DC46CF2BQ35772055-A65F6C91-0FC0-41E5-9B54-0B14C6752E16Q35796917-B3E37689-0684-4B9C-B11E-3DB8FEBD51D0Q35895009-F027EDAC-4F2B-46BF-A767-A3A1D9C0C20DQ35991899-22D8C5E2-A7CA-4A48-83A2-B939A98857A4Q36665699-6BE80F8D-D685-43F6-9A4C-B46ECA358227Q36707357-10FE71F5-BCCC-4BE0-9AF6-59917F1D053EQ36745536-415CD2A9-AD3D-440E-ABB4-FE495B3F7501Q36749622-EE1B5C30-411D-4657-8BE9-298B969A51CEQ36773604-FD8A36EA-E8B8-4CC2-BF53-E456A1D40515Q36995568-E8474335-E81F-4CA3-BDC8-66EB8649039FQ37013071-945C23C9-7885-454A-BFA1-9724E4F2A9E2Q37080859-7BB64CAD-59CC-49D4-8519-B19D5B345ACDQ37218931-21EEF81B-FDBC-44E1-9501-44313726D28DQ37245498-7A1E9B82-955D-4492-8E3D-EE0A31FAAE57Q37935646-C82F86D3-C13E-44B1-8439-737F61867ABCQ38016902-3F3293C8-6C25-45CC-861F-5F1AA1CE60EEQ38081852-F1970A27-7EDF-42F9-917E-4D33BA05CCFFQ38108757-C90D53B3-6ADA-4CB0-ABEE-F60D8C2CDC23Q38220863-54B0607C-018E-45EB-A08B-3A92D8ED87E4Q38358009-22B75E18-5F02-4ECD-B3D9-3FC7E4F29303Q38558006-F727EBD4-7074-4376-B15C-224A51334EBDQ38776961-591B2D7C-D046-4BCF-8EBF-06F69F09E434Q38800009-4491771F-A99A-46C7-BF85-F837CE25D826Q38812324-A6A2A637-36E7-4391-A7B2-A2586E86BB36Q38827901-C8736868-91D2-4161-B3F5-715A496FA9EBQ39012287-2DAFD165-A5F3-4F96-8164-E6B00E7D17C0Q41689680-194F9248-DBBA-42A3-B1E4-D4BB32549A8DQ42049223-B4C9825D-F4E2-4C85-9105-289B85116074
P2860
11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
11C-dihydrotetrabenazine PET o ...... betes and in healthy controls.
@ast
11C-dihydrotetrabenazine PET o ...... betes and in healthy controls.
@en
type
label
11C-dihydrotetrabenazine PET o ...... betes and in healthy controls.
@ast
11C-dihydrotetrabenazine PET o ...... betes and in healthy controls.
@en
prefLabel
11C-dihydrotetrabenazine PET o ...... betes and in healthy controls.
@ast
11C-dihydrotetrabenazine PET o ...... betes and in healthy controls.
@en
P2093
P2860
P50
P1476
11C-dihydrotetrabenazine PET o ...... betes and in healthy controls.
@en
P2093
Dileep Kumar
J John Mann
Martin Prince
Masanori Ichise
Matthew Freeby
Norman Simpson
Paul E Harris
Ramin Parsey
Ronald Van Heertum
Rudolph L Leibel
P2860
P304
P356
10.2967/JNUMED.108.054866
P407
P577
2009-02-17T00:00:00Z